In my latest Guest Column in The Evidence Base, II am joined by my colleague Tiago Beck as we examine how global pricing reforms are reshaping the European pharmaceutical landscape.Building on their session at ISPOR Europe 2025, the column explores the growing tension between EU access ambitions and international policy pressures – offering a timely […]
